CYTOKINE RELEASE SYNDROME
Clinical trials for CYTOKINE RELEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CYTOKINE RELEASE SYNDROME trials appear
Sign up with your email to follow new studies for CYTOKINE RELEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a smart home program help cancer patients recover from CAR-T therapy?
Symptom relief Recruiting nowThis study tests a home-based rehabilitation program for 40 adults with lymphoma or myeloma who are about to receive CAR-T cell therapy. The program includes personalized exercise and nutrition plans, monitored remotely via a web portal and smart technology. The goal is to see if…
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 17, 2026 00:45 UTC
-
New pill aims to tame dangerous immune reactions in cancer treatment
Symptom relief Recruiting nowThis study tests a drug called CTO1681 to prevent or reduce cytokine release syndrome (CRS), a common and serious side effect of CAR T-cell therapy. About 54 adults with diffuse large B-cell lymphoma who are scheduled for CAR T-cell treatment will take CTO1681 three times daily f…
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: CytoAgents, Inc. • Aim: Symptom relief
Last updated May 13, 2026 16:10 UTC
-
Blue dye may tame dangerous immune reactions
Symptom relief Recruiting nowThis early-stage study tests whether adding methylene blue to standard care can safely reduce cytokine release syndrome (CRS) and neurotoxicity (ICANS) in 18 adults who developed these side effects after CAR-T or bispecific antibody treatment. Participants receive methylene blue …
Matched conditions: CYTOKINE RELEASE SYNDROME
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC